Late last night, a divided Fifth Circuit panel (by what was effectively a 2-1 vote) issued a super-complicated ruling freezing *part* of Judge Kacsmaryk’s decision (that had purported to stay the FDA’s approval of mifepristone), but only *part* of it:https://t.co/fESOBgxmhj

— Steve Vladeck (@steve_vladeck) April 13, 2023